1.Division of Gastroenterology, Department of Medicine, Minneapolis VA Medical Center, University of Minnesota, Minneapolis, MN 55147, USA
2.Center of Innovation, Minneapolis VA Medical Center, Minneapolis, MN, USA
3.Department of Medicine, University of Minnesota, Minneapolis, MN, USA
*: ashish.malhotra@va.gov
纸质出版:2016-09
Scan QR Code
All-cause hospitalizations for inflammatory bowel diseases: Can the reason for admission provide information on inpatient resource use? A study from a large veteran affairs hospital[J]. MMR, 2016,3(3):124-128.
Ashish Malhotra, K.C. Mandip, Aasma Shaukat, et al. All-cause hospitalizations for inflammatory bowel diseases: Can the reason for admission provide information on inpatient resource use? A study from a large veteran affairs hospital[J]. Military Medical Research, 2016, 3(3): 124-128.
All-cause hospitalizations for inflammatory bowel diseases: Can the reason for admission provide information on inpatient resource use? A study from a large veteran affairs hospital[J]. MMR, 2016,3(3):124-128. DOI:
Ashish Malhotra, K.C. Mandip, Aasma Shaukat, et al. All-cause hospitalizations for inflammatory bowel diseases: Can the reason for admission provide information on inpatient resource use? A study from a large veteran affairs hospital[J]. Military Medical Research, 2016, 3(3): 124-128. DOI:
Background:
2
Inflammatory bowel diseases (IBDs) are group of chronic inflammatory illnesses with a remitting and relapsing course that may result in appreciable morbidity and high medical costs secondary to repeated hospitalizations. The study’s objectives were to identify the reasons for hospitalization among patients with IBDs
and compare inpatient courses and readmission rates for IBD-related admissions versus non-IBD-related admissions.
Methods:
2
A retrospective chart review was performed on all patients with IBD admitted to the Minneapolis Veterans Affairs (VA) Medical Center between September 2010 and September 2012.
Results:
2
A total of 111 patients with IBD were admitted during the 2-year study period. IBD flares/complications accounted for 36.9% of the index admissions. Atherothrombotic events comprised the second most common cause of admissions (14.4%) in IBD patients. Patients with an index admission directly related to IBD were significantly younger and had developed IBD more recently. Unsurprisingly
the IBD admission group had significantly more gastrointestinal endoscopies and abdominal surgeries
and was more likely to be started on medication for IBD during the index stay. The median length of stay (LOS) for the index hospitalization for an IBD flare or complication was 4(2–8) days compared with 2(1–4) days for the other patients (
P
=0.001). A smaller percentage of the group admitted for an IBD flare/complication had a shorter ICU stay compared with the other patients (9.8%
vs
. 15.7%
respectively); however
their ICU LOSs tended to be longer (4.5
vs
. 2.0 days
respectively
P
=0.17). Compared to the other admission types
an insignificantly greater percentage of the group whose index admission was related to an IBD flare or complication had at least one readmission within 6 months of discharge (29% versus 21%;
P
=0.35). The rate of admission was approximately 80% greater in the group whose index admission was related to an IBD flare or complication compared to the other types of admission (rate ratio 1.8
95% confidence interval 0.96 to 3.4)
although this difference did not reach statistical significance (
P
=0.07).
Conclusion:
2
Identifying the reasons for the patients' index admission
IBD flares versus all other causes
may provide valuable information concerning admission care and the subsequent admission history.
Kappelman M , Rifas-Shiman S , Porter C , Ollendorf D , Sandler R , Galanko J , et al . Direct health care costs of Crohn’s disease and ulcerative colitis in US Children and adults . Gastroenterology . 2008 ; 135 : 1907 - 13 .
Hou JK , Kramer JR , Richardson P , Mei M , El-Serag HB . The incidence and prevalence of inflammatory bowel disease among U.S. veterans: A national cohort study . Inflamm Bowel Dis . 2013 ; 19 ( 5 ): 1059 - 64 .
Kazis LE , Miller DR , Clark J , Skinner K , Lee A , Rogers W , et al . Health-related quality of life in patients served by the department of veterans affairs . Arch Intern Med . 1998 ; 158 ( 6 ): 626 - 32 .
Miehsler W , Reinisch W , Valic E , Osterode W , Tillinger W , Feichtenschlager T , et al . Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut . 2004 ; 53 : 542 - 8 .
Giannotta M , Tapete G , Emmi G , Silvestri E , Milla M . Thrombosis in inflammatory bowel diseases: what’s the link? Thromb J . 2015 ; 13 : 14 .
Targownik LE , Nugent Z , Singh H , Bugden S , Bernstein CN . The prevalence and predictors of opioid use in inflammatory bowel disease: A population-based analysis . Am J Gastroenterol . 2014 ; 109 : 1613 - 20 .
Hanson KA , Loftus EV Jr , Harmsen WS , Diehl NN , Zinsmeister AR , Sandborn WJ . Clinical features and outcome of patients with inflammatory bowel disease who use narcotics: a case-control study . Inflamm Bowel Dis . 2009 ; 15 : 772 - 7 .
Edwards JT , Radford-Smith GL , Florin THJ . Chronic narcotic use in inflammatory bowel disease patients: Prevalence and clinical characteristics . J Gastroenterol Hepatol . 2001 ; 16 : 1235 - 8 .
Cheung M , Khan S , Akerman M , Hung CK , Vennard K , Hristis N , et al . Clinical markers of Crohn’s disease severity and their association with opiate use . J Clin Med Res . 2015 ; 7 ( 1 ): 33 - 6 .
Cross RK , Wilson KT , Binion DG . Narcotic use in patients with Crohn’s disease . Am J Gastroenterol . 2005 ; 100 : 2225 - 9 .
Baser O , Xie L , Mardekian J , Schaaf D , Wang L , Joshi AV . Prevalence of diagnosed opioid abuse and its economic burden in the veterans health administration . Pain Pract . 2014 ; 14 ( 5 ): 437 - 45 .
0
浏览量
0
Downloads
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621